Bayer
Tracked across 12 events · 116 articles · First seen Oct 06, 2025 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.
Feb 17, 2026 · 10 articles
Business
Bayer and BP have formed a long-term strategic alliance to jointly scale the crop camelina, branded as newgold, for use in biofuels. The collaboration will initially focus on North American Cobalt Inc., with BP providing…
Impact: Bayer entered into a long-term strategic alliance with bp to commercialize camelina as a feedstock for biofuels, leveraging its expertise in seed technology and farmer customer base. This alliance is expected to create new revenue streams for Bayer's customers and benefit the renewable fuels market.
May 06, 2026 · 7 articles
Regulatory
Campaigners, led by the Soil Association and supported by groups like Greenpeace and Riverford Organic Farmers, are urging the United Kingdom government to ban the pre-harvest spraying of glyphosate on crops. This call follows studies,…
Impact: Bayer, as part of the Glyphosate Renewal Group and the acquirer of Bayer — Monsanto, is actively seeking the renewal of glyphosate's license in Great Britain. The company has faced numerous lawsuits regarding glyphosate's safety.
May 05, 2026 · 6 articles
Tech
Impact: Bayer's subsidiary, MiNK Therapeutics, is exploring approaches related to regulatory T cells, showing the company's involvement in this emerging field.
Oct 06, 2025 · 6 articles
Business
Boehringer Ingelheim and Immunitas Therapeutics announced a global licensing agreement for a preclinical antibody program targeting chronic inflammatory and autoimmune diseases. Under the terms, Boehringer Ingelheim gains worldwide rights to develop, manufacture, and commercialize the…
Impact: Bayer is listed as an investor supporting Immunitas Therapeutics.
May 12, 2026 · 6 articles
100
Bayer entered alliance BPBayer and BP Scale Camelina
70
Bayer acquired assetsBayer and BP Scale Camelina
60
Bayer introduced newgold camelinaBayer and BP Scale Camelina
NEWSDESK
Track Bayer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard